Rofecoxib improves quality of life in patients with hip or knee osteoarthritis.

  • Theiler R
  • Bischoff H
  • Good M
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

A major goal of osteoarthritis (OA) treatment is pain management to improve function and maximise quality of life. Rofecoxib is a highly selective inhibitor of cyclooxygenase-2 used in symptomatic treatment of inflammation and pain in patients with osteoarthritis of the hip or knee.

Author-supplied keywords

  • WOMAC, SF-12, Quality of life, Rofecoxib, Knee ost

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 12571763

Authors

  • Robert Theiler

  • Heike a Bischoff

  • Meinrad Good

  • Daniel Uebelhart

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free